The subject invention relates a method for the production of monoclonal
antibodies. The method utilizes an immunized animal having
antibody-producing cells with disrupted peripheral tolerance. The
invention also provides a method for the use of such monoclonal
antibodies, and polyclonal antibodies derived from an immunized animal
having antibody-producing cells with disrupted peripheral tolerance, for
in vitro and in vivo clinical diagnostics and therapeutics.